glp-1 milwaukee Anti-Obesity Rx and Alcohol and Substance Use Disorders glp-1 medication milwaukee On a

Giros B, Jaber M, Jones SR, Wightman RM, Caron MG

Diabetic gastroenteropathy (DGE), a prevalent complication of diabetes, impacts the gastrointestinal (GI) tract from the esophagus to the colon, presenting clinical symptoms including esophageal motility disorders, gastroparesis, constipation, diarrhea, and fecal incontinence

This included circumvention of the complex downhill syndrome, as well as a sudden decrease of blood supply, decreased NO levels in the inferior caval vein tissue, an immediate heavy loss of endothelial cells from the vascular wall, a lower eNOS production ability (Rangan and Bulkley, 1993

Standard therapies for OSAS include continuous positive airway pressure (CPAP), weight reduction, upper airway surgery, oral appliances, and neurostimulation

Sources and Further Reading Harvard Health: Understanding GLP-1s for diabetes, weight loss, and beyond UC Davis Health: GLP-1 and health beyond weight loss UCLA Health: Patients taking weight-loss medications require proper nutrition Ohio State Health: Taking a GLP-1